Motivation: Computational models that accurately identify high-affinity protein-compound pairs can accelerate drug discovery pipelines. These models aim to learn binding mechanics through drug-target interaction datasets and use the learned knowledge while predicting the affinity of any protein-compound pair. However, the datasets they rely on bear misleading patterns that bias models towards memorizing dataset-specific biomolecule properties, instead of learning binding mechanics. Insufficiently focused on the binding mechanics, the resulting models struggle while predicting the drug-target affinities (DTA), especially between de novo biomolecules. Here we present DebiasedDTA, the first model debiasing approach that avoids dataset biases in order to boost the affinity prediction on novel biomolecules. DebiasedDTA uses ensemble learning and weight sample adaptation for bias identification and avoidance and is applicable to almost all existing DTA prediction models. Results: The results show that DebiasedDTA can boost models while predicting the interactions between novel biomolecules. Known biomolecules also benefit from the performance boost, though the boost is amplified as the test biomolecules become more dissimilar to the training set. The experiments also show that DebiasedDTA can augment the DTA prediction models of different input and model structures and can avoid biases of different sources. Availability: The source code, the models, and the data sets are available at https://github.com/boun-tabi/debiaseddta-reproduce Contact: arzucan.ozgur@boun.edu.tr, elif.ozkirimli@roche.com